<DOC>
	<DOCNO>NCT01572727</DOCNO>
	<brief_summary>This study evaluate whether addition daily BKM120 weekly paclitaxel effective safe treat patient HER2- locally advance metastatic breast cancer .</brief_summary>
	<brief_title>A Study Experimental Drug BKM120 With Paclitaxel Patients With HER2 Negative , Locally Advanced Metastatic Breast Cancer , With Without PI3K Activation</brief_title>
	<detailed_description>Based efficacy result time interim analysis , DMC recommend stop study Phase II interim meet protocol pre-specified futility criterion . Consequently , Phase III portion study conduct .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Breast cancer locally advance metastatic HER2 negative disease , know hormone receptor status ER/PgR ( common breast cancer classification test ) A tumor sample must ship central lab identification biomarkers ( PI3K activation status ) randomization Adequate bone marrow organ function Measurable nonmeasurable disease Prior chemotherapy locally advance metastatic disease Previous treatment PI3K AKT inhibitor Patient symptomatic CNS metastasis Concurrent malignancy malignancy within 3 year study enrollment Hematopoietic colonystimulating growth factor radiation within 24 week prior start study drug Increasing chronic treatment ( &gt; 5 day ) corticosteroids another immunosuppressive agent Active heart ( cardiac ) disease define protocol Known hypersensitivity contraindication use paclitaxel Pregnant nursing ( lactate ) woman Certain score anxiety depression mood questionaire give screen Other protocol define criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>BKM120</keyword>
	<keyword>paclitaxel</keyword>
	<keyword>breast cancer</keyword>
	<keyword>metastatic</keyword>
	<keyword>locally advanced</keyword>
	<keyword>PI3K</keyword>
	<keyword>PIK3CA</keyword>
	<keyword>PTEN</keyword>
</DOC>